Carlos Collet, MD, Ph.D., joins CRF® as director, cardiovascular imaging, physiology and translational therapeutics
Business Announcement
Updates every hour. Last Updated: 28-Oct-2025 10:11 ET (28-Oct-2025 14:11 GMT/UTC)
The Cardiovascular Research Foundation® (CRF®) is proud to announce the appointment of Dr. Carlos Collet as Director, Cardiovascular Imaging, Physiology and Translational Therapeutics. A globally recognized interventional cardiologist and imaging expert, Dr. Collet will spearhead efforts to accelerate the integration of cutting-edge research into clinical practice, elevate CRF®’s academic contributions, and expand its global leadership in cardiovascular education. His work will unify translational science, technological innovation, and education to advance CRF®’s mission.
HANOVER, Md., U.S.A. and MADRID, Spain – September 9, 2025 – REDIMadrid, the research network of Comunidad de Madrid, managed by IMDEA Software, recently collaborated with Ciena (NYSE: CIEN) on the optical network foundation required to launch its End-to-End Quantum Secure Data Transport Project. The project leverages Ciena’s 6500 photonic line system, which allows a quantum channel to operate seamlessly alongside existing Dense Wavelength Division Multiplexing (DWDM) traffic on the same fiber. This marks a significant milestone in the realm of quantum secure data transport by demonstrating the ability to use Quantum Key Distribution (QKD) technology over existing optical fiber networks.
Bright children from poorer backgrounds are twice as likely to be admitted to hospital with mental health problems than high-achievers with affluent upbringings.